All News

In men treated with dutasteride (Avodart) for prostate cancer, the frequency of acute urinary retention, prostate surgery, and BPH symptoms decreases irrespective of prostate volume or symptom severity.

The Centers for Medicare & Medicaid Services has published the category I CPT code for posterior tibial nerve stimulation (PTNS) in the November 2010 Federal Register, according to Uroplasty Inc., Minneapolis.

When Medicare policy changes led to reductions in reimbursement for androgen deprivation therapy in prostate cancer patients, a sharp decline in its use was seen among patients not likely to benefit from the treatment, reported researchers from the University of Michigan, Ann Arbor.

Urologists and other physicians who treat Medicare patients will see a total reimbursement reduction of 24.9% in 2011 under the Medicare physician fee schedule, according to the recently released Centers for Medicare & Medicaid Services? final rule for 2011.

After years of unsuccessful efforts by numerous investigators, researchers have found a way to propagate primary human Sertoli cells in the laboratory?the first step, say the researchers, to developing an artificial human testicle for reproductive research.

A majority of men dying from prostate cancer wait too long to enroll in hospice care and cannot take full advantage of the palliative care that could make their deaths easier, researchers from UCLA's Jonsson Comprehensive Cancer Center recently reported.

The FDA has asked drug manufacturers to add new warnings to labeling of gonadotropin-releasing hormone agonists to alert patients and health care professionals to the potential risk of heart disease and diabetes in men treated with these medications for prostate cancer.

This free, customizable patient handout provides information on the causes, symptoms, and treatment of kidney stones.

The debate over questions of self referral and inappropriate utilization of medical imaging services by physicians is continuing in Washington, with possibly restrictive recommendations looming from the Medicare Payment Advisory Commission and provisions of the health reform law being implemented.

Findings from a study determining prevalence and concordance rates for urolithiasis in a large twin population point to a major role of genetic factors in determining the risk of stone disease.

Findings from a small observational study suggest a role of vitamin D deficiency in so-called "idiopathic" hypercalciuria and support the need for further research investigating an association between vitamin D deficiency and renal stone formation.